This finding agrees with that of a double-blind study, in which epoetin α produced an improvement in the SF-36 PCS score compared with placebo in anaemic cancer patients receiving nonplatinum chemotherapy (Littlewood et al, 2001). This evidence concerns the gene EPO and cancer.